IntroductionFungal infections, most commonly caused by the dermatophytes species, are one of the most common skin conditions. Historically, these infections have been treated with antifungals such as terbinafine, fluconazole, and itraconazole. Within the past two years, there has been a rise in the incidence of fungal infections resistant to these once effective therapies, particularly emerging in India (1). We now see the spread of the “Indian epidemic” of recalcitrant cases of fungal infections to skin of color in other parts of sub-continental Asia, particularly Pakistan (2). We report a rare case of resistance to oral griseofulvin, terbinafine, and fluconazole in the treatment of tinea corporis.
